HUMAN FAECAL MATTER
Stage 0 Lung Cancer AJCC v8
M.D. Anderson Cancer Centerother_biologicalPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Stage 0 Lung Cancer AJCC v8 cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS M.D. Anderson Cancer Center | Phase 1 | CC |
Vedolizumab M.D. Anderson Cancer Center | Phase 1 | CC |
Infliximab M.D. Anderson Cancer Center | Phase 1 | CC |
Same molecule, other indications
HUMAN FAECAL MATTER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →